ClinicalTrials.gov
public full text
Public Domain
Post-marketing Registry Study of Infliximab for Injection in Chinese Pediatric Crohn's Disease Patients
Post-marketing registration of Infliximab for injection in Chinese pediatric Crohn's disease patients.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- The Impact of Medication Belief on Adherence to Infliximab in Patients With Crohn's Disease#833370
- TDM-based Infliximab Treatment for Active Perianal Fistulizing Crohn's Disease#900502
- Medication Use and Guideline Adherence in Inflammatory Bowel Disease Management: A Retrospective Study from a Tertiary Care Hospital in Pakistan (2019–2024).#244351
- Accu-Chek® CONNECT at School (CATS) Pediatric Study#1058412
- CUP Certolizumab Pegol (CDP-870) in Adults Suffering From Crohn's Disease (CD)#847926
Record · ID 901773
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive